Skip to main content
. Author manuscript; available in PMC: 2015 Jan 16.
Published in final edited form as: Am J Transplant. 2012 Feb 2;12(5):1102–1112. doi: 10.1111/j.1600-6143.2011.03959.x

Figure 5. B cells are not required for BALB LR-PLT transfusions to induce rejection of a BALB.B BMT.

Figure 5

(A) Engraftment results. Engraftment is measured as a percentage of CD229.1+ cells in the peripheral blood of transplant recipients. (B) Alloimmunization to BALB mHAs. BALB specific immunity was measured by in vivo survival of BALB.B splenocyte targets. The mean of each group in (A) and (B) is represented as a horizontal line. Statistics were generated using one-way ANOVA with Dunnett’s post-test. While the illustrated results in (A) and (B) for BALB/c LR-PLT transfused recipients are the combined data from three independent experiments, the data depicted for C57BL/6J LR-PLT transfused recipients are the combined results from two different experiments.